RDIF calls on Italian-Swiss contacts to secure Sputnik V production

Head of the Russian Direct Investment Fund Kirill Dmitriev.
Head of the Russian Direct Investment Fund Kirill Dmitriev. © Reuters
While the European Union is still divided over Russia's Sputnik V vaccine, Moscow's sovereign wealth fund is working its contacts with European pharmaceutical groups, starting with Antonio di Naro's Swiss group Adienne, with the view towards future production. [...] (439 words)
Issue dated 28/04/2021 Reading time 2 minutes
This article may be accessed by subscribers and e-wallet holders (USD 12.50)

2 options offered to continue reading

from EUR/USD 50

Only buy articles you are interested in


Unlimited access to the website

See our rates

Do you want a free trial before subscribing?

Create your free account

Read this article here:

Further reading
On our other sites

Sign up for real-time alerts and be notified of new editions!  

Once registered, you will be notified by a short message on your computer or mobile phone as soon as a new edition of our publication or an alert is published. Stay informed anytime, anywhere!